glp-1 alcohol use disorder RAs may reduce alcohol-related hospitalization risk GLP-1 Weight Loss and Alcohol:

Lorenzo Biasio and Gloria Skibba discuss the integration of Ypsomeds Net Zero Program into its self-injection platforms and explain how YpsoMate 1 and 2.25 mL autoinjectors have been redesigned to achieve a lower carbon footprint

But the big demand for these medications is creating a kind of Wild West, and nutritionists will have to find ways to advocate for their services to help prevent a disaster

Semaglutide is not a replacement for insulin

Animals given semaglutide voluntarily drank less, even when alcohol was freely available

Those who prefer products that have undergone FDA review should consult with healthcare providers to explore approved medication options